Isracann Biosciences raises $234K in Private Plation

Isracann Biosciences Inc. announced that previously shipped genetics have cleared Israeli customs and are being raised as mother stock.

Phil Floucault, CEO of Israel, said the Israeli market will have access to premium Canadian high THC genetics. The three strains we shipped are Liberty Haze, Hell Monkey and Grape Stomper. All three strains have received a positive response from consumers in Canada and I am looking forward to making them available to the Israeli market. The three strains sent were developed as part of United Greeneries Grass Roots genetics program, the goal of which is to produce novel high THC strains with commercially high yields. The three strains are some of the top preforming genetics in the United Greeneries catalogue, which is currently being sold as cannabis flower in Canada. With the support of United Greeneries and Isracann, all three strains have been integrated into the Intelicanna facility and are being prepared as the initial Israeli mother stock.

Floucault said that the teams in Canada and Israel made this genetics shipment go smoothly. The process of scaling to full production is now fully engaged and the growing teams are working to speed up the process. In the near term, Canadian cannabis will be grown in Israel and available to Israeli customers. Israeli-grown Canadian genetics. Cannabis Company Isracann Biosciences Raises $234 K In The First Tranche Of Private Placement